Recap: Harmony Biosciences Q3 Earnings

Harmony Biosciences HRMY reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Harmony Biosciences posted an EPS of $0.95.

Revenue was up $36.47 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.13 which was followed by a 5.59% drop in the share price the next day.

Here's a look at Harmony Biosciences's past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 0.44 0.29 0.37 0.28
EPS Actual 0.57 0.51 0.63 0.51
Revenue Estimate 100.75M 88.55M 90.01M 79.85M
Revenue Actual 107.03M 85.31M 91.21M 80.73M

To track all earnings releases for Harmony Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!